کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2153991 | 1090216 | 2010 | 14 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
تحقیقات سرطان
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
The International Atomic Energy Agency (IAEA) convened a consultants' group meeting to review the current status of 18F-based radiotracers and to suggest means for accelerating their use for diagnostic applications. The consultants reviewed the developments including the synthetic approaches for the preparation of 18F-tracers for oncology and neurosciences. A selection of three groups of 18F-tracers that are useful either in oncology or in neurosciences was done based on well-defined criteria such as application, lack of toxicity, availability of precursors and ease of synthesis. Based on the recommendations of the consultants' group meeting, IAEA started a coordinated research project on “Development of 18F radiopharmaceuticals (beyond [18F]FDG) for use in oncology and neurosciences” in which 14 countries are participating in a 3-year collaborative program. The outcomes of the coordinated research project are expected to catalyze the wider application of several more 18F-radiopharmaceuticals beyond FDG for diagnostic applications in oncology and neurosciences.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Nuclear Medicine and Biology - Volume 37, Issue 7, October 2010, Pages 727-740
Journal: Nuclear Medicine and Biology - Volume 37, Issue 7, October 2010, Pages 727-740
نویسندگان
H.H. Coenen, P.H. Elsinga, R. Iwata, M.R. Kilbourn, M.R.A. Pillai, M.G.R. Rajan, H.N. Jr., J.J. Zaknun,